571-765-7700
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
|
Federal Circuit notes safety and effectiveness of patented medicines are the domain of the FDA not the USPTO
Location Where Hatch-Waxman Notice Letter Received Does Not Establish Venue
|
The Federal Circuit addresses pleading requirements in Hatch-Waxman actions concerning venue and identification of defendants
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
|
Federal Circuit notes safety and effectiveness of patented medicines are the domain of the FDA not the USPTO
Location Where Hatch-Waxman Notice Letter Received Does Not Establish Venue
|
The Federal Circuit addresses pleading requirements in Hatch-Waxman actions concerning venue and identification of defendants